📖
Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL
Aurore Touzart, Etienne Lengliné, Mehdi Latiri, Mohamed Belhocine, Charlotte Smith, Xavier Thomas, Salvatore Spicuglia, Denis Puthier, Francoise Pflumio, Thibaut Leguay, Carlos Graux, Yves Chalandon, Francoise Huguet, Stéphane Lepretre, Norbert Ifrah, Hervé Dombret, Elizabeth Macintyre, Mathilde Hunault-Berger, Nicolas Boissel, Vahid Asnafi

Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL

Science & Mathematics Published 2019 Verification Pending

Overview & Synopsis

Purpose: Biological explanation for discrepancies in patient-related response to chemotherapy depending on the underlying oncogenic events is a promising research area. TLX1- or TLX3-deregulated T-cell acute lymphoblastic leukemias (T-ALL; TLX1/3+) share an immature cortical phenotype and similar transcriptional signatures. However, their prognostic impacts differ, and inconsistent clinical outcome has been reported for TLX3. We therefore hypothesized that the overlapping transcriptional profiles of TLX1+ and TLX3+ T-ALLs would allow identification of candidate genes, which might determine their distinct clinical outcomes.Experimental Design: We compared TLX1+ and TLX3+ adult T-ALL outcome in the successive French national LALA-94 and GRAALL-2003/2005 multicentric trials and analyzed transcriptomic data to identify differentially expressed genes. Epigenetic regulation of asparagine synthetase (ASNS) and in vitro l-asparaginase sensitivity were evaluated for T-ALL cell lines and primary samples.Results: We show that TLX1+ patients expressed low levels of ASNS when compared with TLX3+ and TLX-negative patients, due to epigenetic silencing of ASNS by both DNA methylation and a decrease of active histone marks. Promoter methylation of the ASNS gene correlated with l-asparaginase sensitivity in both T-ALL cell lines and patient-derived xenografts. Finally, ASNS promoter methylation was an independent prognostic factor for both event-free survival [HR, 0.42; 95% confidence interval (CI), 0.24-0.71; P = 0.001] and overall survival (HR, 0.40; 95% CI, 0.23-0.70; P = 0.02) in 160 GRAALL-2003/2005 T-ALL patients and also in an independent series of 47 LL03-treated T lymphoblastic lymphomas (P = 0.012).Conclusions: We conclude that ASNS methylation status at diagnosis may allow individual adaptation of l-asparaginase dose.

Indexed from repository: HAL Open Science (hal.science)
Loading document from verified source...
Keyboard Shortcuts: ← / → for pages • + / - for zoom • 0 to fit width Powered by Mozilla PDF.js v3.11

Document Information

Document Title Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL
Author / Organization Aurore Touzart, Etienne Lengliné, Mehdi Latiri, Mohamed Belhocine, Charlotte Smith, Xavier Thomas, Salvatore Spicuglia, Denis Puthier, Francoise Pflumio, Thibaut Leguay, Carlos Graux, Yves Chalandon, Francoise Huguet, Stéphane Lepretre, Norbert Ifrah, Hervé Dombret, Elizabeth Macintyre, Mathilde Hunault-Berger, Nicolas Boissel, Vahid Asnafi
Subject & Discipline Multidisciplinary Academic Open Research
Categories Science & Mathematics
Publication Year 2019
License / Rights Open Access / Creative Commons
Resource Verification Listed PDF (Verification Pending)
Original Host Website HAL Open Science (hal.science)
File Format application/pdf (Portable Document Format)
Language EN
Catalog ID DOC-163688
Original Source Link Visit Source Page on hal.science »